Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Cash flows from operating activities    
Net loss $ (239,663) $ (52,840)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,172 3,147
Amortization of deferred contract acquisition costs 4,920 8,006
Amortization of deferred loan cost 66  
Net amortization of premium on marketable securities 558  
Stock-based compensation expense 250,835 8,201
Non-cash operating lease costs 1,734 1,879
(Benefit from) provision for bad debt (709) 29
Deferred income taxes 21 (52)
Changes in operating assets and liabilities:    
Accounts receivable 35,973 9,769
Contract assets (8,148) (4,781)
Deferred contract acquisition costs (20,205) (5,782)
Prepaid expenses and other assets 7,666 1,109
Accounts payable (528) 4,251
Accrued expense and other liabilities 4,573 (1,646)
Accrued compensation and employee benefits (60,433) (8,340)
Operating lease liabilities, net (1,807) (1,894)
Deferred revenue 4,453 14,812
Net cash used in operating activities (17,522) (24,132)
Cash flows from investing activities    
Purchases of marketable securities (94,157)  
Sales of marketable securities 89,383  
Maturities of marketable securities 23,755  
Purchases of property and equipment (2,200) (460)
Capitalization of software development costs (410)  
Payment related to business acquisition, net of cash acquired (5,498)  
Net cash provided by (used in) investing activities 10,873 (460)
Cash flows from financing activities    
Proceeds from initial public offering, net of underwriting discounts and commissions 692,369  
Payments of initial public offering costs (2,406)  
Proceeds from issuance of convertible preferred stock 750,000  
Payments of issuance costs for convertible preferred stock (164)  
Proceeds from exercise of stock options 3,114 536
Proceeds from credit facility   78,828
Net cash provided by financing activities 1,442,913 79,364
Effect of exchange rate changes 2,313 7,955
Net increase in cash, cash equivalents and restricted cash 1,438,577 62,727
Cash, cash equivalents and restricted cash - beginning of period 371,190 234,131
Cash, cash equivalents and restricted cash - end of period 1,809,767 296,858
Supplemental disclosure of cash flow information    
Cash paid for interest 214 368
Cash paid for income taxes 3,076 455
Supplemental disclosure of non-cash investing and financing activities    
Stock-based compensation capitalized for software development 2,151  
Value of shares issued in payment of business acquisition 30,446  
Deferred offering costs, accrued but not yet paid 1,328  
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options 1,646  
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid $ 9,218  
Deferred payments related to business acquisitions   $ 18,269